MedPAC Continues Review of Physician Payment Reforms
Physician payment reforms, MIPS challenges and value-based care took center stage at MedPAC’s October meeting.
Read moreMain Content
FDA Update on Oversight of AI-Enabled Healthcare Technologies
March 21, 2024
The U.S. Food and Drug Administration (FDA) published a paper March 15, to update the public about intra-agency activities to oversee artificial intelligence (AI)-enabled healthcare technologies. The paper summarizes priorities shared across the biologics, drugs and medical devices domains of FDA jurisdiction.
Four general focus areas are discussed: fostering collaboration with stakeholders; developing appropriate regulatory approaches; promoting development of standards and best practices; and supporting research on performance evaluation. Moving forward, the FDA intends to evolve its own regulatory approaches with the continued progression of AI tools.
For more information about various American College of Radiology®(ACR®) AI-specific initiatives, visit the ACR Data Science Institute®. For more information about FDA oversight and digital health policy, contact Michael Peters, ACR Senior Government Affairs Director.
Related ACR News
Patients First Act with ROOT Act
Senate lawmakers introduced the Patients First Act, including ACR-backed reforms to Medicare physician payment and imaging policy.
Read moreComments About CMS RAPID Coverage Pathway
The College backed faster Medicare access to innovative devices while urging CMS to preserve strong evidence standards and clinical input.
Read more
